Search - tctmd.com

Displaying 141 - 160 of 694

Sort: Relevancy | Date

Presentation TCT 2019

MAC Types and Clinical Implications

Presenter: Philipp Blanke

September 28, 2019

Presentation TCT 2019

PROPOT: A Randomized Trial of the Proximal Optimization Technique in Coronary Bifurcation Lesions

Presenter: Ken Kozuma

September 28, 2019

Presentation TCT 2019

STOPDAPT, SMART-CHOICE, and TWILIGHT: Will These Trials Change Your Clinical Practice?

Presenter: Aditya Kapoor

September 28, 2019

Presentation TCT 2019

Transcatheter Mitral Valve Repair and Replacement Clinical Trial Designs After COAPT and MITRA-FR

Presenter: Gregg Stone

September 28, 2019

Presentation TCT 2019

TRILUMINATE Trial: 6-Month Outcomes of Percutaneous Edge-to-Edge Repair for Tricuspid Regurgitation

Presenter: Georg Nickenig

September 28, 2019

Presentation TCT 2019

PARTNER 2 Trial and Registry: Impact of Left And Right Ventricular Longitudinal Systolic Strain Following Transcatheter and Surgical Aortic Valve Replacement

Presenter: Philippe Pibarot

September 28, 2019

News Conference News TCT 2019

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

Michael O'Riordan

September 28, 2019

Presentation TCT 2019

DEFINE-FLAIR: 2-Year Outcomes From a Randomized Trial of iFR and FFR Decision-Making in Patients With Coronary Artery Disease

Presenter: Justin Davies

September 28, 2019

CIN Prevention II: Clinical Trials Summary of Completed and Ongoing Studies

Presentation TCT 2019

CIN Prevention III: Clinical Trials Summary of Completed and Ongoing Studies

Presenter: Somjot Brar

September 28, 2019

Presentation TCT 2019

Is it TWILIGHT for Aspirin? Critical Appraisal and Interpretation of the Trial

Presenter: Pascal Vranckx

September 28, 2019

Presentation TCT 2019

My Strategy for Interpreting (And Critiquing) Non-Inferiority Studies

Presenter: Sanjay Kaul

September 28, 2019

Presentation TCT 2019

TAVR in Low-Risk Patients: Strengths and Limitations of the Low-Risk Trials

Presenter: Robert Bonow

September 28, 2019

Presentation TCT 2019

The Challenges of Equipoise and Generalizability

Presenter: Robert Yeh

September 28, 2019

Presentation TCT 2019

MODERATO II: A Double-Blind Randomized Trial of Cardiac Neuromodulation Therapy in Patients With Hypertension

Presenter: Karl-Heinz Kuck

September 28, 2019

Presentation TCT 2019

When Trials Disagree: The COAPT/MITRA-FR Case Study

Presenter: Milton Packer

September 28, 2019

Presentation TCT 2019

Use of Repeat Events and Allowance for Competing Risk: How to Do It Right

Presenter: Andrew Althouse

September 28, 2019

News Conference News TCT 2019

COAPT at 3 Years: Crossover Patients See Benefits From MitraClip

Shelley Wood

September 28, 2019

Presentation TCT 2019

Innovative Trial Designs in Device-Based Hypertension Treatment

Presenter: Konstantinos Tsioufis

September 28, 2019

Debate: Is a Clinical Outcomes Trial Mandatory Before Widespread Adoption of Device-Based Hypertension Therapies? - Yes, An Outcomes Study for Device-Based Hypertension Approaches Is Needed Before Widespread Use Can Be Recommended!

Presentation TCT 2019

Yes, An Outcomes Study for Device-Based Hypertension Approaches Is Needed Before Widespread Use Can Be Recommended!

Presenter: Bernard Gersh

September 28, 2019

Debate: Is a Clinical Outcomes Trial Mandatory Before Widespread Adoption of Device-Based Hypertension Therapies? - No: An Outcomes Study for Device-Based Hypertension Approaches Is NOT Necessary Before Widespread Use Can Be Recommended!

Presentation TCT 2019

No: An Outcomes Study for Device-Based Hypertension Approaches Is NOT Necessary Before Widespread Use Can Be Recommended!

Presenter: Andrew Sharp

September 28, 2019

Advertisement

MAC Types and Clinical Implications

PROPOT: A Randomized Trial of the Proximal Optimization Technique in Coronary Bifurcation Lesions

STOPDAPT, SMART-CHOICE, and TWILIGHT: Will These Trials Change Your Clinical Practice?

Transcatheter Mitral Valve Repair and Replacement Clinical Trial Designs After COAPT and MITRA-FR

TRILUMINATE Trial: 6-Month Outcomes of Percutaneous Edge-to-Edge Repair for Tricuspid Regurgitation

PARTNER 2 Trial and Registry: Impact of Left And Right Ventricular Longitudinal Systolic Strain Following Transcatheter and Surgical Aortic Valve Replacement

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

DEFINE-FLAIR: 2-Year Outcomes From a Randomized Trial of iFR and FFR Decision-Making in Patients With Coronary Artery Disease

CIN Prevention III: Clinical Trials Summary of Completed and Ongoing Studies

Is it TWILIGHT for Aspirin? Critical Appraisal and Interpretation of the Trial

My Strategy for Interpreting (And Critiquing) Non-Inferiority Studies

TAVR in Low-Risk Patients: Strengths and Limitations of the Low-Risk Trials

The Challenges of Equipoise and Generalizability

MODERATO II: A Double-Blind Randomized Trial of Cardiac Neuromodulation Therapy in Patients With Hypertension

When Trials Disagree: The COAPT/MITRA-FR Case Study

Use of Repeat Events and Allowance for Competing Risk: How to Do It Right

COAPT at 3 Years: Crossover Patients See Benefits From MitraClip

Innovative Trial Designs in Device-Based Hypertension Treatment

Yes, An Outcomes Study for Device-Based Hypertension Approaches Is Needed Before Widespread Use Can Be Recommended!

No: An Outcomes Study for Device-Based Hypertension Approaches Is NOT Necessary Before Widespread Use Can Be Recommended!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content